4//SEC Filing
Nuechterlein Carole 4
Accession 0001567619-21-012335
CIK 0001799448other
Filed
Jun 16, 8:00 PM ET
Accepted
Jun 17, 5:09 PM ET
Size
5.6 KB
Accession
0001567619-21-012335
Insider Transaction Report
Form 4
Nuechterlein Carole
Director
Transactions
- Award
Stock Option (Right to Buy)
2021-06-17+15,000→ 15,000 totalExercise: $26.58Exp: 2031-06-17→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]The shares subject to the option will vest and become exercisable as to 100% of the total number of shares subject to the option on the earlier of the first anniversary of the grant date or the day prior to the annual meeting in 2022 of the Issuer's stockholders, assuming continuous service as a director until such vesting date.
Documents
Issuer
Aligos Therapeutics, Inc.
CIK 0001799448
Entity typeother
Related Parties
1- filerCIK 0001665133
Filing Metadata
- Form type
- 4
- Filed
- Jun 16, 8:00 PM ET
- Accepted
- Jun 17, 5:09 PM ET
- Size
- 5.6 KB